Zhengye Biotechnology Holding Ltd (ZYBT) stock
ZYBTNasdaqPharmaceutical Preparations
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 28, 2026Score 4/30
$1.50−0.02 (-1.32%)
Close on Nov 18, 2026Market cap $71.09MP/E –Yield –
Zhengye Biotechnology profit margin
Profit margin (net margin) is net income as a percentage of revenue.
For fiscal 2025 it was -60.0%, against 6.1% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -60.0% | −66.0 |
| FY2024 | Dec 31, 2024 | 6.1% | −8.8 |
| FY2023 | Dec 31, 2023 | 14.9% | −3.1 |
| FY2022 | Dec 31, 2022 | 18.0% | – |
See a number that looks wrong?